Can a smartphone app lift depression? new study puts syrenity to the test
NCT ID NCT06408025
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study investigates whether the Syrenity mental health app can reduce depressive symptoms in adults with moderate to severe depression. Participants use the app, which includes exposure-based and behavioral activation exercises, and their progress is tracked with weekly questionnaires. The trial compares the app to a waiting list control and also measures how usable and acceptable the app is.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Syrenity mental health app (exposure-based and behavioral activation interventions)
What this could lead to
If effective, the Syrenity app could offer a convenient, accessible tool to help people manage depressive symptoms on their own.
What could go wrong
This is an early-stage trial comparing the app to a waiting list, so results may not prove it works better than other treatments. The app's benefits may also vary by individual.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE SYMPTOMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- rTMS & Exercise for MCI & Depression - NCT07652775
- iMATTER: Preventing Teen Depression in Primary C NCT07020572
- Metformin for Depression-Obesity Comorbidity (NCT07654179)
- Intranasal Esketamine-Dexmedetomidine for Postpa NCT07639099
- JAK signaling in depression and cognition in mal NCT07608796
- Understanding Decision Making via Text Game | NCT05925816
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Indiana University
Bloomington, Indiana, 47408, United States